Inaba A. et al, (2023), Nature Communications, 14
Zhang J-Y. et al, (2023), Genome Medicine, 15
Suomi T. et al, (2023), EBioMedicine, 92
Low-dose IL-2 reduces IL-21+ T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes
Zhang J-Y. et al, (2022), Nature Communications, 13
Circulating C-Peptide Levels in Living Children and Young People and Pancreatic β-Cell Loss in Pancreas Donors Across Type 1 Diabetes Disease Duration.
Carr ALJ. et al, (2022), Diabetes, 71, 1591 - 1596
INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes.
Dunger DB. et al, (2022), Trials, 23
Therapeutically expanded human regulatory T-cells are super-suppressive due to HIF1A induced expression of CD73.
Jarvis LB. et al, (2021), Commun Biol, 4
Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes.
Robertson CC. et al, (2021), Nature genetics
Single-cell multi-omics analysis reveals IFN-driven alterations in T lymphocytes and natural killer cells in systemic lupus erythematosus
Trzupek D. et al, (2021), Wellcome Open Research, 6, 149 - 149
Therapeutically expanded human regulatory T-cells are super- suppressive due to HIF1A induced expression of CD73.
Jarvis L. et al, (2020)